BRIEF-Biovie Initiates Sunrise-Pd Clinical Trial Assessing Bezisterim In Early Parkinson’S Disease With First Patient Enrolled

Reuters
16 Apr
BRIEF-Biovie Initiates Sunrise-Pd Clinical Trial Assessing Bezisterim In Early Parkinson’S Disease With First Patient Enrolled

April 16 (Reuters) - BioVie Inc BIVI.O:

  • BIOVIE INITIATES SUNRISE-PD CLINICAL TRIAL ASSESSING BEZISTERIM IN EARLY PARKINSON’S DISEASE WITH FIRST PATIENT ENROLLED

  • BIOVIE INC - TOPLINE DATA EXPECTED IN LATE 2025 OR EARLY 2026

Source text: ID:nGNX79w2KG

Further company coverage: BIVI.O

((Reuters.Briefs@thomsonreuters.com;))

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Most Discussed

  1. 1
     
     
     
     
  2. 2
     
     
     
     
  3. 3
     
     
     
     
  4. 4
     
     
     
     
  5. 5
     
     
     
     
  6. 6
     
     
     
     
  7. 7
     
     
     
     
  8. 8
     
     
     
     
  9. 9
     
     
     
     
  10. 10